Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma protein and venous thromboembolism: prospective cohort and mendelian randomisation analyses. | Br J Haematol | 2023 | 36734038 | PubTator, text mining | PubMed |
| MiR-7-5p/KLF4 signaling inhibits stemness and radioresistance in colorectal cancer. | Cell Death Discov | 2023 | 36732504 | PubTator, text mining | PubMed |
| Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer. | J Exp Clin Cancer Res | 2023 | 36717865 | PubTator, text mining | PubMed |
| Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. | Cell Rep Med | 2023 | 36702123 | PubTator, text mining | PubMed |
| Factors associated with general practitioners' routines and comfortability with assessing female genital cutting: a cross-sectional survey. | BMC Health Serv Res | 2023 | 36698125 | PubTator, text mining | PubMed |
| Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma. | Mol Cancer Ther | 2023 | 36696581 | PubTator, text mining | PubMed |
| TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment. | J Immunother Cancer | 2023 | 36693679 | PubTator, text mining | PubMed |
| Screening cell-cell communication in spatial transcriptomics via collective optimal transport. | Nat Methods | 2023 | 36690742 | PubTator, text mining | PubMed |
| Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis. | Genet Res (Camb) | 2023 | 36688087 | PubTator, text mining | PubMed |
| Selection methods for proximity-dependent enrichment of ligands from DNA-encoded libraries using enzymatic fusion proteins. | Chem Sci | 2023 | 36687357 | PubTator, text mining | PubMed |
| Differential Susceptibility of Fetal Retinal Pigment Epithelial Cells, hiPSC- Retinal Stem Cells, and Retinal Organoids to Zika Virus Infection. | Viruses | 2023 | 36680182 | PubTator, text mining | PubMed |
| Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer. | Molecules | 2023 | 36677808 | PubTator, text mining | PubMed |
| Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients. | Int J Mol Sci | 2023 | 36674471 | PubTator, text mining | PubMed |
| MIA/CD-RAP Regulates MMP13 and Is a Potential New Disease-Modifying Target for Osteoarthritis Therapy. | Cells | 2023 | 36672165 | PubTator, text mining | PubMed |
| Network-based identification and prioritization of key transcriptional factors of diabetic kidney disease. | Comput Struct Biotechnol J | 2023 | 36659918 | PubTator, text mining | PubMed |
| Phosphorylation of TRF2 promotes its interaction with TIN2 and regulates DNA damage response at telomeres. | Nucleic Acids Res | 2023 | 36651296 | PubTator, text mining | PubMed |
| Incorporating microglia-like cells in human induced pluripotent stem cell-derived retinal organoids. | J Cell Mol Med | 2023 | 36644817 | PubTator, text mining | PubMed |
| Ginseng polysaccharides: Potential antitumor agents. | J Ginseng Res | 2023 | 36644386 | PubTator, text mining | PubMed |
| Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial. | J Transl Med | 2023 | 36635690 | PubTator, text mining | PubMed |
| A non-catalytic N-terminus domain of WRN prevents mitotic telomere deprotection. | Sci Rep | 2023 | 36635307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=24